DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a regional employer contract for behavioral health, and a strategic partnership in the provider market that will allow Dario solutions to be sold through a network of practices across the United States. The two new contracts mark a key milestone for Dario, b
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital therapeutic beginning in the first quarter of 2022.
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 15, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its third quarter 2021 operational and financial results and filed its Form 10-Q . Dario hosted a conference call the following morning to discuss results in further detail. Dario’s growth is accelerating with